Niche CNS Focus Target opportunities in Central Nervous System clinical trials, including bipolar disorder, schizophrenia, depression, and Alzheimer’s disease, as well as broader cardiac, diabetes, and infectious disease studies to align with their current trial capabilities.

Midmarket Capacity Position as a compliant CRO-capable site for Phase I through IV studies with 11-50 employees, emphasizing agility, personalized site management, and potential for faster patient enrollment in niche CNS and comorbidity trials.

Regional Presence Leverage South Florida footprint in Miami to target regional sponsors and investigator-initiated trials, highlighting access to diverse patient populations and potential concierge regulatory support in the local market.

Education & Engagement Align with the founder’s mission of patient education by offering patient-centered recruitment materials, informed consent enhancements, and community outreach programs to improve enrollment quality and retention.

Growth Enablement Propose strategic partnerships, contract research services expansion, and capability buildouts (pilot programs, translational research, data management) to scale revenue beyond the current sub-million revenue range and attract mid-size sponsors.